US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
カナダ
TSX
EQB Inc (EQB.R) 銘柄情報

EQB Inc (EQB.R)

48.44

0.00

(0.00%)

終了 7月9日 5:12AM

EQB Inc (EQB.R) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

48.44

( - )

買値

47.50

売値

58.97

出来高

-

平均取引量 (3 か月)

$ 91,861

財務取引量

-

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

時価総額

企業価値

-

前日終値

48.44

始値

-

時刻

最終取引時間

VWAP

-

歳入

1.06B

純利益

198.15M

発行済株式数

35,434,112

浮動株比率 (%)

68.79%

機関投資家保有比率 (%)

34.40%

配当利回り

2.24 (2.08%)

PER

27.62

株価売上高倍率 (PSR)

4.65

1 株当たり利益 (EPS)

5.04

ベータ

1.31

EQB Inc., through its subsidiary, Equitable Bank, provides personal and commercial banking services to retail and commercial customers in Canada. It accepts term deposits, guaranteed investment certificates, high-interest savings accounts, institutional deposit notes, and covered bonds, as well as s... EQB Inc., through its subsidiary, Equitable Bank, provides personal and commercial banking services to retail and commercial customers in Canada. It accepts term deposits, guaranteed investment certificates, high-interest savings accounts, institutional deposit notes, and covered bonds, as well as specialized financing solutions. The company also offers single-family residential mortgages, reverse mortgages, and home equity lines of credit, as well as insurance loans. In addition, it provides business enterprise solutions, commercial finance group services, multi-unit insured financing, specialized finance, equipment leasing, credit union services, and Concentra Trust services, as well as digital banking services. The company was formerly known as Equitable Group Inc. and changed its name to EQB Inc. in June 2022. EQB Inc. was founded in 1970 and is headquartered in Toronto, Canada. 詳細を表示

セクター

-

業界

-

ウェブサイト

eqb.investorroom.com

本社

Toronto, Canada

設立

1970

EQB Inc is listed in the sector of the トロント証券取引所 with ticker EQB.R. The last closing price for EQB was $48.44. Over the last year, EQB shares have traded in a share price range of $ 0.00 to $ 0.00.

EQB currently has 35,434,112 shares in issue. The market capitalisation of EQB is $1.72 billion. EQB has a price to earnings ratio (PE ratio) of 27.62.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

EQB.R - Frequently Asked Questions (FAQ)

What is the current EQB Inc share price?

The current share price of EQB Inc is $ 48.44

How many EQB Inc shares are in issue?

EQB Inc has 35,434,112 shares in issue

What is the market cap of EQB Inc?

The market capitalisation of EQB Inc is CAD 1.72B

What is the 1 year trading range for EQB Inc share price?

EQB Inc has traded in the range of $ 0.00 to $ 0.00 during the past year

What is the PE ratio of EQB Inc?

The price to earnings ratio of EQB Inc is 27.62

What is the cash to sales ratio of EQB Inc?

The cash to sales ratio of EQB Inc is 4.65

What is the registered address of EQB Inc?

The registered address for EQB Inc is EQ Bank Tower, Toronto, Ontario, M5A 0Y9

What is the EQB Inc website address?

The website address for EQB Inc is eqb.investorroom.com

sentiment_stocks

sentiment_stocks 22秒前

Wait, did I miss something?

That also raises the future filing issue. A peer reviewed PSM paper may help a future FDA BLA, but it would not make an MHRA rejection disappear. FDA’s first question would still be: why did MHRA say no after more than 2.5 years?

As I stated

Ocean Power

Ocean Power 1分前

Up 19* today with 122k at ask of 83* and 27k more in the afternoon …

SSKILLZ1

SSKILLZ1 1分前

SSKMP Managed Index (As Of 7/8/26)

Daily Performance
-0.68%

YTD Performance
+5.79%

Overall Performance
+525.53% (Including Options Trading +389.51%)

JamesF1

JamesF1 2分前

imanjen13, The news regarding Alkermes and Amneal is about generic Vivitrol, Naltrexone suspension for injection. Elite makes Naltrexone tablets. Unfortunately this news has nothing to do with Elite.

gfp927z

gfp927z 2分前

>>> Katie Couric reveals diagnosis of temporary memory-robbing condition

NBC News

by David K. Li

7-8-26

https://www.msn.com/en-us/health/other/katie-couric-reveals-diagnosis-of-temporary-memory-robbing-condition/ar-AA27tJZr?

Wizzerd

Wizzerd 4分前

The 3 points takeaways from this SEC filing.
1. Greater transparency. By filing an 8-K, TWOH is informing all shareholders of a material event through an official SEC filing rather than relying solely on a press release. That can improve investor confidence.
2. A significant corporate

flipper44

flipper44 4分前

I said they should, instead of them trying to use some evasive language, but you changed that to me stating they would, and had an argument against yourself.

You do this constantly to people.

my3sons87

my3sons87 5分前

Thanks Paullee for the transsion information. Hopefully, IDCC will announce a settlement with transsion next.

mr_sano

mr_sano 7分前

The company has gone from ~135 million shares in 2015 to over 550 million shares today. That’s more than 4x dilution in about 10 years, all while generating zero revenue from their product.
And it’s about to get worse.
With only ~199 million authorized shares remaining, they are likely

DrHigh

well if Linda said it then it must be true. Because she has historically delivered on previous forward looking statements

end sarcasm

Arturosurfer

Arturosurfer 8分前

I was worried but I’m not giving up hope.

sentiment_stocks

sentiment_stocks 9分前

Although for NWBO, 4-5 PR's within the 6 months following approval would feel like a Biblical level flood of information.
On occasion, you do make me laugh.

larrybaz

larrybaz 9分前

Nasdaq.com's Revenue/EPS page is now gone apparently. My old link doesn't work, and I don't see the link where it used to be on the page. Maybe it's behind a pay wall now. I don't know.

I was able to find a workaround, though. Here is a link to the Spanish language version:

FeMike

FeMike 10分前

What did I misunderstand Flip?

You said that NWBO should announce a partnership at the same time as approval.

I said that is too optimistic, even if a handshake deal is in place, it won't get done like that.

You disagreed.

So what am I misu

vlispxpert

vlispxpert 10分前

10Y/USD spiked, BUT both sold today & look topped short term imo, another clue this may be a false market breakdown:

https://schrts.co/IsvNMTIP

Fire_starter

Fire_starter 11分前

ITS NOW OR NEVER NUCLEAR SHORT SQUEEZE OR THE BIGGEST SCAM IN STOCK MARKET HISTORY

crazy horse 0

crazy horse 0 12分前

The potential is there

Amazing! We are obviously on the cusp of major medical breakthroughs and I have no doubt that RespireRX will be included.

flipper44

flipper44 13分前

Again, your reading comprehension is abysmal. You change what people say, than argue against that.

Golden Cross

Golden Cross 14分前

$BATL US bombing Iran for 2nd straight day after Trump declares cease-fire with ‘sick’ regime ‘over’
https://nypost.com/2026/07/08/us-news/us-bombing-iran-for-2nd-straight-day-after-trump-declares-cease-fire-over-for-sick-regime/

This is good for BATL pps going up here!

nowwhat2

nowwhat2 14分前

https://investorshub.advfn.com/uimage/uploads/2026/7/8/ghzpemillennials_GUTSI_crypto_investing.jpg

surfkast

surfkast 14分前

He gets spanked again.

https://media1.giphy.com/media/v1.Y2lkPTc5MGI3NjExM3MzaTZxenRxMTk5cnNneG02OGRjMWZ0cDV2Z2Z0ZmIyMWt0OHBjeSZlcD12MV9naWZzX3NlYXJjaCZjdD1n/pRotk2UQTsozm/200.webp

Golden Cross

Golden Cross 14分前

$BATL US bombing Iran for 2nd straight day after Trump declares cease-fire with ‘sick’ regime ‘over’
https://nypost.com/2026/07/08/us-news/us-bombing-iran-for-2nd-straight-day-after-trump-declares-cease-fire-over-for-sick-regime/

This is good for BATL pps going up here!

joe botts

joe botts 15分前

FeMike

FeMike 15分前

Okay Flip.

Keep the pump strong. Can't wait to hear your excuses when a partnership isn't announced at the same time as approval.

OMX Baltic Energy GI

Mitsu Hc Cap.23

Simply Better Brands

Thermo Fisher Scientific

Volcanic Gold Mines

iShares Global Corp Bond...

Smartfit Escola De Ginas... (PK)

Arctic Hunter Energy

Mensch and Maschine Soft...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。